Up-regulation of Anxa2 gene promotes proliferation and invasion of breast cancer MCF-7 cells

Cell Proliferation

Volumn 45, Issue 3, 2012, Pages 189-198

  Wu, B ^a   Zhang, F ^a   Yu, M ^b   Zhao, P ^a   Ji, W ^a   Zhang, H ^a   Han, J ^a   Niu, R ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLIN D1; LIPOCORTIN 2; MYC PROTEIN; SMALL INTERFERING RNA; STAT3 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INVASION; CARCINOGENICITY; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL STRAIN MCF 7; CELL SURVIVAL; COLONY FORMATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; METASTASIS; MOUSE; NONHUMAN; TUMOR CELL; TUMOR PROMOTION; TUMOR VOLUME; WESTERN BLOTTING;

ANIMALS; ANNEXIN A2; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CYCLIN D1; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; MICE; MICE, NUDE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEOPLASM INVASIVENESS; PROTO-ONCOGENE PROTEINS C-MYC; RNA INTERFERENCE; RNA, SMALL INTERFERING; S PHASE; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TRANSPLANTATION, HETEROLOGOUS; UP-REGULATION;

EID: 84862797610     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/j.1365-2184.2012.00820.x     Document Type: Article

References (35)

1. Beck WT (1990) Mechanisms of multidrug resistance in human tumor cells. The roles of P-glycoprotein, DNA topoisomerase II, and other factors. Cancer Treat. Rev. 17, 11-20.
2. Beck WT (1987) Pharmacological, molecular, and cytogenetic analysis of "atypical" multidrug-resistant human leukemic cells. Cancer Res. 47, 5455-5460.
3. Yao HX, Zhang ZQ, Xiao ZQ, Chen YH, Li C, Zhang PF et al. (2009) Identification of metastasis associated proteins in human lung squamous carcinoma using two-dimensional difference gel electrophoresis and laser capture microdissection. Lung Cancer 65, 41-48.
4. Ohno Y, Izumi M, Kawamura T, Nishimura T, Mukai K, Tachibana M (2009) Annexin II represents metastatic potential in clear-cell renal cell carcinoma. Br. J. Cancer 101, 287-294.
5. Pei HP, Zhu H, Zeng S, Li YX, Yang HX, Shen LF et al. (2007) Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancerProteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer. J. Proteome Res. 6, 2495-2501.
6. Sharma MR, Koltowski L, Ownbey RT, Tuszynski GP, Sharma MC (2006) Angiogenesis -associated protein annexin II in breast cancer: selective expression in invasive breast cancer and contribution to tumor invasion and progression. Exp. Mol. Pathol. 81, 146-156.
7. Wu W, Tang X, Hu W, Lotan R, Hong WK, Mao L (2002) Identification and validation of metastasis-associated proteins in head and neck cancer cell lines by two-dimensional electrophoresis and mass spectrometry. Clin. Exp. Metastasis 19, 319-326.
8. Zhang F, Zhang L, Zhang B, Wei XY, Yang Y, Qi RZ et al. (2009) Anxa2 plays a critical role in enhanced invasiveness of the multidrug resistant human breast cancer cells. J. Proteome Res. 8, 5041-5047.
9. Li QQ, Wang WJ, Xu JD, Cao XX, Chen Q, Yang JM et al. (2007) Involvement of CD147 in regulation of multidrug resistance to P-gp substrate drugs and in vitro invasion in breast cancer cells. Cancer Sci. 98, 1064-1069.
10. Li QQ, Wang WJ, Xu JD, Cao XX, Chen Q, Yang JM et al. (2007) Up-regulation of CD147 and matrix metalloproteinase-2, -9 induced by P-glycoprotein substrates in multidrug resistant breast cancer cells. Cancer Sci. 98, 1767-1774.
11. Zhao P, Zhang W, Tang J, Ma XK, Dai JY, Li Y et al. (2007) Annexin II promotes invasion and migration of human hepatocellular carcinoma cells in vitro via its interaction with HAb18G/CD147. Cancer Sci. 101, 387-395.
12. Tang JP, Tan CP, Li J, Siddique MM, Guo K, Chan SW et al. (2010) VHZ is a novel centrosomal phosphatase associated with cell growth and human primary cancers. Mol Cancer. 9, 128.
13. Burysek L, Syrovets T, Simmet T (2002) The serine protease plasmin triggers expression of MCP-1 and CD40 in human primary monocytes via activation of p38 MAPK and janus kinase (JAK)/STAT signaling pathways. J. Biol. Chem. 277, 33509-33517.
14. Xuan YT, Guo Y, Zhu Y, Wang OL, Rokosh G, Messing RO et al. (2005) Role of the protein kinase C-epsilon-Raf-1-MEK-1/2-p44/42 MAPK signaling cascade in the activation of signal transducers and activators of transcription 1 and 3 and induction of cyclooxygenase-2 after ischemic preconditioning. Circulation 112, 1971-1978.
15. Caplan JF, Filipenko NR, Fitzpatrick SL, Waisman DM (2004) Regulation of annexin A2 by reversible glutathionylation. J. Biol. Chem. 279, 7740-7750.
16. Chen CL, Loy A, Cen L, Chan C, Hsieh FC, Cheng G et al. (2007) Signal transducer and activator of transcription 3 is involved in cell growth and survival of human rhabdomyosarcoma and osteosarcoma cells. BMC Cancer 7, 111.
17. Takano S, Togawa A, Yoshitomi H, Shida T, Kimura F, Shimizu H et al. (2008) Annexin II overexpression predicts rapid recurrence after surgery in pancreatic cancer patients undergoing gemcitabine-adjuvant chemotherapy. Ann. Surg. Oncol. 15, 3157-3168.
18. Motokura T, Arnold A (1993) PRAD1/cyclin D1 proto-oncogene: genomic organization, 5′ DNA sequence, and sequence of a tumor-specific rearrangement breakpoint. Genes Chromosomes Canc. 7, 89-95.
19. Quelle DE, Ashmun RA, Shurtleff SA, Kato JY, Bar-Sagi D, Roussel MF et al. (1993) Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev. 7, 1559-1571.
20. Mohammad HS, Kurokohchi K, Yoneyama H, Tokuda M, Morishita A, Jian G et al. (2008) Annexin A2 expression and phosphorylation are up-regulated in hepatocellular carcinoma. Int. J. Oncol. 33, 1157-1163.
21. Zhang Y, Zhou ZH, Bugge TH, Wahl LM (2007) Urokinase-type plasminogen activator stimulation of monocyte matrix metalloproteinase-1 production is mediated by plasmin-dependent signaling through annexin A2 and inhibited by inactive plasmin. J. Immunol. 179, 3297-3304.
22. Alfonso P, Canamero M, Fernandez-Carbonie F, Nunez A, Casal JI (2008) Proteome analysis of membrane fractions in colorectal carcinomas by using 2D-DIGE saturation labeling. J. Proteome Res. 7, 4247-4255.
23. Emoto K, Yamada Y, Sawada H, Fujimoto H, Ueno M, Takayama T et al. (2001) Annexin II overexpression correlates with stromal tenascin-C overexpression: a prognostic marker in colorectal carcinoma. Cancer 92, 1419-1426.
24. Emoto K, Sawada H, Yamada Y, Fujimoto H, Takahama Y, Ueno M et al. (2001) Annexin II overexpression is correlated with poor prognosis in human gastric carcinoma. Anticancer Res. 21, 1339-1345.
25. Spano F, Raugei G, Palla E, Colella C, Melli M (1990) Characterization of the human lipocortin-2-encoding multigene family: its structure suggests the existence of a short amino acid unit undergoing duplication. Gene 95, 243-251.
26. Cole SP, Pinkoski MJ, Bhardwaj G, Deeley RG (1992) Elevated expression of annexin II (lipocortin II, p36) in a multidrug resistant small cell lung cancer cell line. Br. J. Cancer 65, 498-502.
27. Li Y, Hong X, Hussain M, Sarkar SH, Li R, Sarkar FH (2005) Gene expression profiling revealed novel molecular targets of docetaxel and estramustine combination treatment in prostate cancer cells. Mol. Cancer Ther. 4, 389-398.
28. Chuthapisith S, Bean BE, Cowley G, Eremin JM, Samphao S, Layfield R et al. (2009) Annexins in human breast cancer: possible predictors of pathological response to neoadjuvant chemotherapy. Eur. J. Cancer 45, 1274-1281.
29. Mickleburgh I, Burtle B, Hollas H, Campbell G, Chrzanowska-Lightowlers Z, Vedeler A et al. (2005) Annexin A2 binds to the localization signal in the 3′ untranslated region of c-myc mRNA. FEBS J. 272, 413-421.
30. Filipenko NR, MacLeod TJ, Yoon CS, Waisman DM (2004) Annexin A2 is a novel RNA-binding protein. J. Biol. Chem. 5, 8723-8731.
31. Jimenez B, del Peso L, Montaner S, Esteve P, Lacal JC (1995) Generation of phosphorylcholine as an essential event in the activation of Raf-1 and MAP-kinases in growth factors-induced mitogenic stimulation. J. Cell. Biochem. 57, 141-149.
32. Shah BH, Catt KJ (2004) Matrix metalloproteinases in reproductive endocrinology. Trends Endocrinol. Metab. 15, 47-49.
33. Ye S (2006) Influence of matrix metalloproteinase genotype on cardiovascular disease susceptibility and outcome. Cardiovasc. Res. 69, 636-645.
34. Beloueche-Babari M, Jackson LE, Al-SAffar NM, Workman P, Leach MO, Ronen SM (2005) Magnetic resonance spectroscopy monitoring of mitogen-activated protein kinase signaling inhibition. Mounia Beloueche-Babari Cancer Res. 65, 3356-3363.
35. Johnson GL, Lapadat R (2002) Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298, 1911-1912.